Business
CardioComm Solutions' HeartCheck(TM) and SMART Monitoring ECG Technologies used in Colorado State University Coordinated Canine Atrial Fibrillation Clinical Trial
TORONTO, ON / ACCESSWIRE / November 25, 2015 / CardioComm Solutions, Inc. (TSXV: EKG) ("Card...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CardioComm Solutions' HeartCheck(TM) and SMART Monitoring ECG Technologies used in Colorado State University Coordinated Canine Atrial Fibrillation Clinical TrialTORONTO, ON / ACCESSWIRE / November 25, 2015 / CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm Solutions\" or the \"Company\") a global medical provider of consumer heart monitoring and medical electrocardiogram (\"ECG\") software solutions, today confirmed a research collaboration with the Colorado State University, College of Veterinary Medicine and Biomedical Sciences, funded by the American Kennel Club Canine Health Foundation (\"CHF\"), allowing both researchers and owners of dogs with cardiac arrhythmias to monitor their pets from home.\nCardioComm Solutions, Inc. is providing a method by which veterinary cardiologists can monitor cardiac rhythm of dogs with heart disease and sustained atrial fibrillation (AF). When Dr. Jan Bright, a professor of cardiology at Colorado State University (CSU), was seeking a means of closely monitoring the ECG of dogs participating in a clinical trial, she chose to provide owners with HeartCheck(TM) handheld ECG devices for weekly ECG recordings of participating dogs. The clinical trial is evaluating usefulness of a novel medication for maintaining normal cardiac rhythm following cardioversion of AF. Although the HeartCheck(TM) devices are designed for handheld recording in people, these devices have a detachable ECG cable with three electrodes which can be easily attached to and removed from the footpads of canine patients. The recordings obtained are viewed and stored on the device and also transmitted through the Company's Windows based GEMS(TM) Home software for analysis. \nAtrial fibrillation (AF) is a common heart rhythm abnormality, or arrhythmia, in dogs and affects all dog breeds. AF frequently coexists with heart failure (HF) causing worsening of HF and high mortality. AF may be managed by administering drugs to slow heart rate or by restoring normal rhythm using a direct current synchronized shock (DC cardioversion). The study entitled \"Efficacy of Ranolazine for Preventing Relapse of Atrial Fibrillation in Dogs with Heart Disease (Grant #02046) will evaluate the ability of ranolazine to prolong the duration of normal cardiac rhythm in dogs with AF and heart disease after DC cardioversion. Cardiac rhythm is evaluate...